What is it about?
This study investigates the effectiveness of telenursing in improving tuberculosis (TB) treatment compliance, particularly amidst the COVID-19 pandemic. Using a Randomized Controlled Trial design and PRISMA, researchers sourced relevant articles from databases like Scopus and PubMed. Findings suggest that telenursing serves as a viable solution to enhance TB patients' adherence to treatment regimens by providing remote support, reminders, and education. This approach becomes crucial during the pandemic, offering a means to reduce the spread of COVID-19 while maintaining quality care for TB patients.
Featured Image
Photo by CDC on Unsplash
Why is it important?
Our research explores the innovative use of telenursing to address TB treatment challenges exacerbated by the COVID-19 pandemic. As healthcare delivery shifts towards telehealth modalities, understanding the efficacy of telenursing in promoting treatment compliance becomes increasingly relevant. By demonstrating its effectiveness in improving adherence and reducing missed doses, our findings contribute valuable insights to the evolving landscape of telemedicine and public health strategies during global health crises.
Perspectives
Being involved in this study has highlighted the potential of telenursing to bridge gaps in healthcare delivery, particularly in the context of infectious disease management during crises like the COVID-19 pandemic. Witnessing how remote nursing interventions can positively impact TB treatment outcomes underscores the importance of leveraging technology to enhance patient care and support. As we navigate unprecedented challenges in healthcare, integrating innovative solutions like telenursing offers hope for more resilient and patient-centered healthcare systems.
Mr Ferry Efendi
Universitas Airlangga
Read the Original
This page is a summary of: A systematic review on telenursing as a solution in improving the treatment compliance of tuberculosis patients in the COVID-19 pandemic, Healthcare in Low-resource Settings, February 2023, PAGEPress Publications,
DOI: 10.4081/hls.2023.11194.
You can read the full text:
Contributors
The following have contributed to this page
